Status:
COMPLETED
Dual-Energy CT in Patients With Head and Neck Squamous Cell Carcinomas
Lead Sponsor:
Ottawa Hospital Research Institute
Collaborating Sponsors:
GE Healthcare
Conditions:
Head and Neck Squamous Cell Carcinoma
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to utilize dual-energy computed tomography (DECT) to investigate changes in tumor iodine concentration in patients with head and neck squamous cell carcinomas (HNSCC). Dua...
Detailed Description
Patients with head and/or neck tumors routinely have head and neck imaging completed with a computerized tomography scan, commonly called a CT scan. A CT scan combines a series of x-ray views that are...
Eligibility Criteria
Inclusion
- 18 years and older
- untreated, histologically confirmed head and neck squamous cell carcinoma
Exclusion
- paranasal sinus involvement of head and neck squamous cell carcinoma
Key Trial Info
Start Date :
April 14 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 15 2019
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT02279459
Start Date
April 14 2015
End Date
April 15 2019
Last Update
August 6 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Ottawa Hospital
Ottawa, Ontario, Canada, K1Y 4E9